Stellanin-PEG, 3% ointment, 20g

Composition

>

of 100 g of ointment for external use contains:  

Active ingredient:  

1,3-diethylbenzimidazolium triiodide – 3.0 g;

Auxiliary substances:  

povidone (low molecular weight polyvinylpyrrolidone),

dimexide,

polyethylene oxide 1500 (polyethylene glycol 1500),

polyethylene oxide 400 (polyethylene glycol 400).

Pharmacological action

The mechanism of pharmacological activity of the drug is the antibacterial effect of 1,3-diethylbenzimidazolium.

Active iodine, which is part of 1,3-diethylbenzimidazolium triiodide, inactivates bacterial wall proteins and bacterial enzyme proteins, thereby exerting a bactericidal effect on microorganisms. The pronounced antimicrobial effect of the drug prevents infection of wounds.

Along with antibacterial and anti-inflammatory effects, the ointment has a high osmotic potential, which is especially important in the treatment of purulent wounds, because it helps to evacuate purulent discharge from the wound defect.

Pharmacokinetics

Systemic absorption of the Active ingredient is absent even with damaged skin, however, therapeutic concentrations of the drug are present in the wound.

Indications

• Treatment of acute purulent processes (RAS) of skin and soft tissues (boils, carbuncles, hidradenitis, cellulitis, abscess);
• adjunctive treatment of purulent complications of postoperative wounds (after excision, coagulation, episiotomy, for the treatment of cracked skin, wounds and sutures);
• thermal injury of the skin and soft tissues of I-III degree, complicated infectious process;
• trophic ulcers, bedsores, complicated infectious process.
• abrasions, cuts, scratches, cracks, scratching.

Use during pregnancy and lactation

It is forbidden to take Stellanin-PEG in the first trimester of pregnancy.

Use with caution in the second and third trimesters of pregnancy and lactation.

Contraindications

• Hypersensitivity to the components of Stellanin-PEG,
• thyrotoxicosis,
• thyroid adenoma,
• severe renal failure,
• concomitant therapy with radioactive iodine,
• children under 18 years of age,
• I trimester of pregnancy.

With caution:  chronic renal failure, II and III trimesters of pregnancy, lactation.

Side effects

In rare cases, allergic skin reactions (itching, hyperemia of the skin) are possible, if they occur, the drug should be discontinued.

Interaction

Do not use Stellanin-PEG in combination with other antiseptics containing mercury, oxidizing agents, alkalis and cationic surfactants.

An alkaline or acidic environment, the presence of fat, pus, and blood weaken the antiseptic activity.

How to take, course of use and dosage

The ointment is applied in a thin layer of about 1.5-2 mm directly to the wound surface, after which a sterile gauze dressing is applied or the drug is applied to the dressing material, and then to the wound. The ointment layer should exceed the circumference of the wound size by at least 5 mm.

Swabs soaked in ointment loosely fill the cavities of purulent wounds after their surgical treatment, and gauze turunds with the drug are inserted into the fistulous passages. If the wound is located in an inconvenient place for bandaging, it is permissible to use a band-aid or adhesive bandage.

Bandages are changed 1-2 times a day.

The daily dose should not exceed 10 g. The average duration of treatment is 5-15 days.

For minor skin injuries (abrasions, cuts, scratches, cracks, combs), the drug is applied in a thin layer on the affected surface 2 times a day.

Overdose

Cases of overdose are not described.

If the drug is accidentally taken orally, nausea and vomiting may occur.

It is necessary to wash the stomach and consult a doctor, if necessary, conduct symptomatic treatment.

Special instructions

Avoid contact with the ointment in the eyes.

If the drug gets into the eyes, rinse with warm water.

Form of production

Ointment for external use.

Storage conditions

The drug should be stored in a dry place, protected from light, at a temperature of 0-25 °C. Keep out of reach of children.

Shelf

life is 2 years.

Active ingredient

Diethylbenzimidazolium triiodide

Dosage form

ointment